Transdermal delivery of drugs based on crystal size
AssigneeNoven Pharmaceuticals, Inc.
InventorViet Nguyen
Life of this patent
Estimating the term…
Abstract
A blend of at least two polymers in combination with a drug provides a pressure-sensitive adhesive composition for a transdermal drug delivery system in which the drug is delivered from the pressure-sensitive adhesive composition and through dermis when the pressure-sensitive adhesive composition is in contact with human skin. According to the invention, providing drug having differing crystal sizes as well as drug which is solublized in the pressure-sensitive adhesive composition controls the rate of drug delivery from the pressure-sensitive adhesive composition.
Claims23
A transdermal drug delivery system comprising a pressure sensitive adhesive composition which comprises a blend of:
- (a) one or more polymers selected from the group consisting of a rubber based polymer, an acrylic based polymer and a polysiloxane;
- and
- (b) a pharmacologically effective amount at least one drug for transdermal drug delivery, wherein said at least one drug is (i) solubilized in said pressure sensitive adhesive, (ii) incorporated in said pressure sensitive adhesive in crystal form having a small crystal size, and (iii) incorporated in said pressure sensitive adhesive in crystal form having a larger crystal size,
- wherein the amount of drug solubilized in said pressure sensitive adhesive, the amount of drug incorporated in said pressure sensitive adhesive in crystal form having a small crystal size, and the amount of drug incorporated in said pressure sensitive adhesive in crystal form having a larger crystal size are selectively tailored to control the drug delivery rate and profile of the drug from the transdermal drug delivery system.
A transdermal drug delivery system comprising a pressure sensitive adhesive composition comprising a blend of:
- (a) one or more polymers selected from the group consisting of a rubber based polymer, an acrylic based polymer and a polysiloxane, present in an amount from 5% to 97% by weight of said pressure sensitive adhesive composition;
- and
- (b) a pharmacologically effective amount at least one drug for transdermal drug delivery, wherein said at least one drug is (i) solubilized in said pressure sensitive adhesive, (ii) incorporated in said pressure sensitive adhesive in crystal form having a small crystal size of from about 1 μm to about 200 μm, and (iii) incorporated in said pressure sensitive adhesive in crystal form having a larger crystal size of from about 100 μm to about 2000 μm,
- wherein the amount of drug solubilized in said pressure sensitive adhesive, the amount of drug incorporated in said pressure sensitive adhesive in crystal form having a small crystal size, and the amount of drug incorporated in said pressure sensitive adhesive in crystal form having a larger crystal size are selectively tailored to control the drug delivery rate and profile of the drug from the transdermal drug delivery system.
Dependencies are inferred from the claim text.